高清不卡日本v二区在线,天天综合网天天综合,激情丁香五月天婷婷水蜜桃视频,91精品免费久久久久久久久,手机看片久久久久久久久,日日夜夜嫩草,日本不卡 在线视频,欧美亚洲日韩,高潮歹无毛免费观看视频,天天综合网7799日日夜夜永,欧美日本国产日韩激情视频 ,久久久无码精品亚洲日韩蜜桃,日夜夜天天人人综合网,91蜜桃长长久久,国产精品精品一区在线发布,一级a毛片免费观看久久精品

Can you provide an overview of the general timeline for FDA registration and certification?
Category:行業(yè)資訊 Date:2024-08-27 16:49:30 Author: Source:
Note: These timelines are estimates and can vary based on the quality of the submission, the completeness of the information provided, and the FDA's current workload. For the most accurate and specific details, consulting with the FDA or a regulatory expert is recommended.

Certainly! Here’s an overview of the general timeline for FDA registration and certification:7.jpg

  1. FDA Device Registration and Listing:

    • Typical Timeframe: A few days to a couple of weeks. This involves submitting basic information about the device and manufacturer. The process is relatively straightforward and quick if no additional information is required.
  2. 510(k) Premarket Notification:

    • Standard Review: Approximately 90 days. The FDA reviews the submission to determine if the device is substantially equivalent to a legally marketed device. This timeframe can be extended if the FDA requests more information or if the submission is complex.
  3. Premarket Approval (PMA):

    • Standard Review: Around 180 days. This process is for high-risk devices and involves a thorough review of clinical and non-clinical data. The timeline can extend if additional data is needed or if there are complex issues.
    • Priority Review: For devices that qualify, the review can be completed in about 150 days.
  4. De Novo Classification:

    • Standard Review: Generally about 150 days, but it can be longer if additional information is required.
  5. Investigational Device Exemption (IDE):

    • Standard Review: Typically about 30 days, though this can vary based on the study’s complexity and additional information needs.

Note: These timelines are estimates and can vary based on the quality of the submission, the completeness of the information provided, and the FDA's current workload. For the most accurate and specific details, consulting with the FDA or a regulatory expert is recommended.

Contact Us:

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn